Post-marketing Clinical Study of Irbesartan <Evaluation of safety and efficacy of long-term administration>

Trial Profile

Post-marketing Clinical Study of Irbesartan <Evaluation of safety and efficacy of long-term administration>

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 May 2016

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Hypertension
  • Focus Adverse reactions
  • Sponsors Sumitomo Dainippon Pharma
  • Most Recent Events

    • 27 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top